medigraphic.com
Órgano Oficial del Hospital Angeles Health System

2021, Number 2

<< Back Next >>

Acta Med 2021; 19 (2)

COVID-19 in patients with chronic hemodialysis. Clinical experience and results in Mexico City

Ramos GJ, Méndez VC, Patiño OR, Hernández VL, Dávila PD, Magallanes MM, Ruiz PP, Rogel MA, Peña RJC

Language: Spanish
References: 28
Page: 221-228
PDF size: 198.96 Kb.


ABSTRACT

Introduction: This is a report of COVID-19 in chronic hemodialysis patients. Material and methods: This is a retrospective and observational study in chronic hemodialysis patients. All patients diagnosed with COVID-19 from April 1st to July 15th 2020 were included. The diagnosis was established with real-time polymerase chain reaction (RT-PCR) from throat and nose swabbing, in all suspected cases. Results: 373 suspected cases were identified (10%), 160 (40%) were confirmed cases. With an incidence of 4.3%; 66 females and 94 males: average age 55 ± 15 years (20-88 years), 73 people died (45%). The ratified diagnosis of all such cases were: Diabetic nephropathy 64 cases (40%), unknown cause 46 cases (28%), nephrosclerosis 31 (19%) and other causes 12%. The most common symptoms were: fever, cough, dyspnea and diarrhea. The average value of oxygen saturation in suspected cases was 81 ± 7%. Lymphocyte count was lower in patients who died. Conclusion: The percent mortality in this group of patients in maintenance hemodialysis was very high (45%) in comparison with the general population (5-10%). Of these, 40% were diabetics. All patients that developed acute respiratory syndrome died.


REFERENCES

  1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395 (10223): 497-506.

  2. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382 (18): 1708-1720.

  3. World Health Organization. Novel Coronavirus (2019-nCov) Situation Report-163, 2020. [Acceso 20 de julio de 2020] Available in: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200701-covid-19-sitrep-163

  4. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395 (10229): 1054-1062.

  5. Yi Y, Lagniton PNP, Ye S, Li E, Xu RH. COVID-19: what has been learned and to be learned about the novel coronavirus disease. Int J Biol Sci. 2020; 16 (10): 1753-1766.

  6. Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. 2020; 5 (7): 831-840.

  7. Zhu J, Ji P, Pang J, Zhong Z, Li H, He C et al. Clinical characteristics of 3062 COVID-19 patients: a meta-analysis. J Med Virol. 2020; 92 (10): 1902-1914. doi: 10.1002/jmv.25884.

  8. Ma Y, Diao B, Lv X, Zhu J, Liang W, Liu L el al. 2019 novel coronavirus disease in hemodialysis (HD) patients: report from one HD center in Wuhan, China. medRxiv. 2020. doi: 10.1101/2020.02.24.20027201.

  9. Valeri AM, Robbins-Juarez SY, Stevens JS, Ahn W, Rao MK, Radhakrishnan J et al. Presentation and outcomes of patients with ESKD and COVID-19. J Am Soc Nephrol. 2020; 31 (7): 1409-1415.

  10. Aydin Bahat K, Parmaksiz E, Sert S. The clinical characteristics and course of COVID-19 in hemodialysis patients. Hemodial Int. 2020; 24 (4): 534-540. doi: 10.1111/hdi.12861.

  11. Kliger AS, Cozzolino M, Jha V, Harbert G, Ikizler TA. Managing the COVID-19 pandemic: international comparisons in dialysis patients. Kidney Int. 2020; 98 (1): 12-16.

  12. Vega-Vega O, Arvizu-Hernández M, Domínguez-Cherit JG, Sierra-Madero J, Correa-Rotter R. Prevención y control de la infección por coronavirus SARS-CoV-2 (COVID-19) en unidades de hemodiálisis. Salud Publica Mex. 2020; 62 (3): 341-347.

  13. Institute Health of Metrics Evaluation. [Acceso en septiembre de 2020] Sitio web: https://covid19.healthdata.org/mexico?view=total-deaths&tab=trend

  14. Kunutsor SK, Laukkanen JA. Renal complications in COVID-19: a systematic review and meta-analysis. Ann Med. 2020; 52 (7): 345-353. doi: 10.1080/07853890.2020.1790643.

  15. Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020; 97 (5): 829-838.

  16. Xiong F, Tang H, Liu L, Tu C, Tian JB, Lei CT et al. Clinical Characteristics of and Medical Interventions for COVID-19 in Hemodialysis Patients in Wuhan, China. J Am Soc Nephrol. 2020; 31 (7): 1387-1397.

  17. Vaziri ND, Pahl MV, Crum A, Norris K. Effect of uremia on structure and function of immune system. J Ren Nutr. 2012; 22 (1): 149-156.

  18. Betjes MG. Immune cell dysfunction and inflammation in end-stage renal disease. Nat Rev Nephrol. 2013; 9 (5): 255-265. doi: 10.1038/nrneph.2013.44.

  19. Kwan BC, Leung CB, Szeto CC, Wong VW, Cheng YL, Yu AW et al. Severe acute respiratory syndrome in dialysis patients. J Am Soc Nephrol. 2004; 15 (7): 1883-1888.

  20. Naicker S, Yang CW, Hwang SJ, Liu BC, Chen JH, Jha V. The Novel Coronavirus 2019 epidemic and kidneys. Kidney Int. 2020; 97 (5): 824-828.

  21. Goicoechea M, Sánchez Cámara LA, Macías N, Muñoz de Morales A, Rojas AG, Bascuñana A et al. COVID-19: clinical course and outcomes of 36 hemodialysis patients in Spain. Kidney Int. 2020; 98 (1): 27-34.

  22. Wu J, Li J, Zhu G, Zhang Y, Bi Z, Yu Y et al. Clinical features of maintenance hemodialysis patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. Clin J Am Soc Nephrol. 2020; 15 (8): 1139-1145.

  23. Li J, Xu G. Lessons from the experience in Wuhan to reduce risk of COVID-19 infection in patients undergoing long-term hemodialysis. Clin J Am Soc Nephrol. 2020; 15 (5): 717-719.

  24. Ferrey AJ, Choi G, Hanna RM, Chang Y, Tantisattamo E, Ivaturi K et al. A case of novel coronavirus disease 19 in a chronic hemodialysis patient presenting with gastroenteritis and developing severe pulmonary disease. Am J Nephrol. 2020; 51 (5): 337-342.

  25. Alberici F, Delbarba E, Manenti C, Econimo L, Valerio F, Pola A et al. A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection. Kidney Int. 2020; 98 (1): 20-26.

  26. Henry BM, Lippi G. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. Int Urol Nephrol. 2020; 52 (6): 1193-1194.

  27. Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020; 17 (5): 259-260.

  28. Pio-Abreu A, do Nascimento MM, Vieira MA, de Menezes Neves PDM, Lugon JR, Sesso R. High mortality of CKD patients on hemodialysis with Covid-19 in Brazil. J Nephrol. 2020; 33 (5): 875-877. doi: 10.1007/s40620-020-00823-z.




2020     |     www.medigraphic.com